Tryptase levels in coronary syndromes and in hypersensitivity episodes: A common pathway towards Kounis syndrome

Atherosclerosis

Volumn 219, Issue 1, 2011, Pages 28-29

  Kounis, Nicholas G ^a   Tsigkas, Grigorios ^a   Almpanis, George ^a   Kounis, George N ^a   Mazarakis, Andreas ^a   Hahalis, George ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Acute coronary syndromes; Hypersensitivity; Kounis syndrome; Plaque stability; Tryptase

Indexed keywords

HIGH DENSITY LIPOPROTEIN; PROTEINASE; TRYPTASE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ALLERGY; ANAPHYLAXIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR EFFECT; CHINESE; ENZYME BLOOD LEVEL; ENZYME RELEASE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERSENSITIVITY; INFLAMMATION; ISCHEMIC HEART DISEASE; KOUNIS SYNDROME; MAJOR CLINICAL STUDY; MAST CELL; MASTOCYTOSIS; MEDIATOR; NOTE; PRIORITY JOURNAL; ST SEGMENT DEPRESSION;

BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; PLAQUE, ATHEROSCLEROTIC; TRYPTASES;

EID: 80054988626     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.07.101     Document Type: Note

References (24)

1. Lopez P.R., Peiris A.N. Kounis syndrome. South Med J 2010, 103:1148-1155.
2. Kounis N.G. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm?. Int J Cardiol 2006, 110:7-14.
3. Kounis N.G., Kouni S.N., Koutsojannis C.M. Myocardial infarction after aspirin treatment, and Kounis syndrome. J R Soc Med 2005, 98:296.
4. Xiang M., Sun J., Lin Y., et al. Usefulness of serum tryptase level as an independent biomarker for coronary plaque instability in a Chinese population. Atherosclerosis 2011, 215:494-499.
5. Metcalfe D.D., Schwartz L.B. Assessing anaphylactic risk? Consider mast cell clonality. J Allergy Clin Immunol 2009, 123:687-688.
6. Filipiak K.J., Tarchsalska-Krynska B., Opolski G., et al. Tryptase levels in patients with acute coronary syndromes: the potential new marker in unstable plaque?. Clin Cardiol 2003, 26:366-372.
7. Deliargyris E.N., Upadhya B., Sane D.C., et al. Mast cell tryptase: a new biomarker in patients with stable coronary artery disease. Atherosclerosis 2005, 178:381-386.
8. Scwartz L.B. Tryptase from human mast cells: biochemistry, biology and clinical utility. Monogr Allergy 1990, 27:90-113.
9. Castells M., Irani A.A., Scwartz L.B. Evaluation of human peripheral blood leucocytes for mast cell tryptase. J Immunol 1987, 138:2814-2819.
10. Thomas V.A., Wheeless C.J., Stack M.S., Johnson D.A. Human mast cell tryptase fibrinogenolysis: kinetics, anticoagulation mechanism, and cell adhesion disruption. Biochemistry 1998, 37:2291-2298.
11. Schwartz L.B., Lewis R.A., Austen K.F. Tryptase from human pulmonary mast cells. Purification and characterization. J Biol Chem 1981, 256:n11939-n11943.
12. Jackson C.L., Angelini G.D., George S.J. Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 1998, 18:1707-1715.
13. Fajardo I., Pejler G. Human mast cell beta-tryptase is a gelatinase. J Immunol 2003, 171:1493-1499.
14. Lee-Rueckert M., Kovanen P.T. Mast cell proteases: physiological tools to study functional significance of high density lipoproteins in the initiation of reverse cholesterol transport. Atherosclerosis 2006, 189:8-18.
15. Meyer M.C., Creer M.H., McHowat J. Potential role for mast cell tryptase in recruitment of inflammatory cells to endothelium. Am J Physiol Cell Physiol 2005, 289:C1485-C1491.
16. Molino M., Barnathan E.S., Numerof R., et al. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 1997, 272:4043-4049.
17. Lombardini C., Helia R.E., Boehlen F., Merlani P. Heparinization and hyperfibrinogenolysis by wasp sting. Am J Emerg Med 2009, 27. p. 1176.e1-1176.e3.
18. Cuculo A., Summaria F., Schiavino D., et al. Tryptase levels are elevated during spontaneous ischemic episodes in unstable angina but not after ergonovine test in variant angina. Cardiologia 1998, 43:189-193.
19. Kovanen P.T., Kaartinen M., Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995, 92:1083-1088.
20. Valent P., Spanbloshe E., Sperr W.R., et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor (CSF)/kit ligand (KL) in long-term culture. Blood 1992, 80. 2337-2245.
21. Irani A.A., Nilsson G., Miettinen U., et al. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 1992, 80:3009-3021.
22. Mazarakis A., Koutsojannis C.M., Kounis N.G., Alexopoulos D. Cefuroxime-induced coronary artery spasm manifesting as Kounis syndrome. Acta Cardiol 2005, 60:341-345.
23. Bonadonna P., Perbellini O., Passalacqua G., et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 2009, 123:680-686.
24. Akin C., Scott L.M., Kocabas C.N., et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with " idiopathic" anaphylaxis. Blood 2007, 110:2331-2333.